Bill of Health

APRIL 24, 2023

My latest article, Public Health Product Hops (forthcoming 2023, American University Law Review, available on SSRN ), represented my long-form attempt to reconcile our differing opinions on product hopping. The first draft was completed about a week before Dmitry’s death, and it was workshopped for the first time with Professor I.

Public Health 313

Public Health FDA Bioethics Governance 313

Bill of Health

JULY 27, 2023

face challenges in court, the legal, public health, medical, and bioethics communities have an essential role to play both in properly framing the legal issue, as well as explaining what is truly at stake in these cases to minimize the chances of similarly harmful rulings for the transgender community moving forward.

Bioethics 130

Bioethics Public Health Governance Doctors 130

Bill of Health

NOVEMBER 30, 2022

State pharmaceutical bans and restrictions — which are often medically unnecessary and instead based largely on policymakers’ moral and political views — impede the FDA’s mandate to protect and promote the public health. In appropriate circumstances, states could seek an exemption to address a state-specific public health need.

FDA 176

FDA Bioethics Public Health Governance 176

Bill of Health

JULY 28, 2022

We hosted a series of workshops with choice of law experts and research law and ethics experts to identify factors that are most crucial to account for in a future choice of law precision medicine research framework. Glenn Cohen (Harvard Law School), Nita Farahany (Duke University School of Law), and Hank Greely (Stanford Law School).

Bioethics 144

Bioethics COVID-19 Public Health 144